Recruiting PHASE2 Acne

New treatment option for Acne

Official title Topical Application of Engineered Lactobacillus Reuteri With a Zinc Sulfate-Tannic Acid MPN Coating for Acne

ClinicalTrials.gov ID: NCT07366229

What this study is testing

What is MPN-coated engineered Lactobacillus reuteri cream?

MPN-coated engineered Lactobacillus reuteri cream is an investigational medicine, given as a treatment applied to the skin, being studied as a potential treatment for acne.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
A growing body of evidence suggests that the development and progression of acne are closely linked to an imbalance in the skin's microbial community. Compared to healthy skin, the composition and function of the microbiota in acne lesions are significantly altered.
  • Phase 2: a mid-size study of how well it works
  • Time commitment: about 2 weeks
  • You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 33

You may be able to join if

  • people must be diagnosed with acne (based on history, clinical manifestation, and dermatoscopy) and classified as Grade I to III per the...
  • people must be willing and able to provide written informed consent.
  • people must be 18 to 33 years of age and in generally good health.
  • people must have more than 9 inflammatory lesions.

You likely can't join if

  • Have used antibiotics within 1 month before the study start.
  • Have used systemic retinoid therapy within 3 months before the study start.
  • Have undergone any other acne treatment within 1 month before the study start.
  • Have any other condition that the investigator considers would make participation unsuitable (e.g., deemed unreliable, non-compliant, or unable to...

The study team makes the final eligibility decision.

Where it's taking place

  • Shenzhen, Guangdong, China

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The study runs about 2 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 33 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Shenzhen, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.